2024年美国临床肿瘤学会胃肠肿瘤研讨会(American Society of Clinical Oncology Gastrointestinal Cancers Symposium,ASCO-GI)于当地时间1月18-20日在美国旧金山举行.本次大会报道的多个研究将对食管癌的临床实践产生重要影响.本文将从食管癌的手术方式、围手术期免疫治疗、晚期食管癌药物治疗和免疫治疗耐药后解救治疗等角度出发,整理及解读此次大会中食管癌领域的重要进展.
Interpretation of the progress in esophageal cancer treatment in the 2024 American Society of Clinical Oncology Gastrointestinal Cancer Symposium
The 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium(ASCO-GI)was held in San Francisco,the USA from January 18th to 20th,2024(local time).The multiple studies presented in this symposium will have a significant impact on the clinical practice of esophageal cancer.This article will focus on the surgical methods of esophageal cancer,perioperative immunotherapy,drug therapy for advanced esophageal cancer,rescue treatment after immunotherapy resistance,and other relevant aspects.It aims to summarize and interpret the significant advancements in the field of esophageal cancer presented in this symposium.
NETL
NSTL
万方数据
